vindesine has been researched along with Hematologic Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beuzeboc, P; Chauveinc, L; Clough, KB; Cosset, JM; de la Rochefordière, A; Guyonnet, M; Mouret-Fourme, E; Nguyen, D | 1 |
| Emmert, S; Haenssle, H; Kretschmer, L; Neumann, C; Zutt, M | 1 |
| Albain, KS; Bitran, JD; Blough, RR; DeMeester, TR; Golomb, HM; Hoffman, PC; Noble, S; Skosey, C | 1 |
| Akdas, A; Coninx, P; De Pauw, M; Denis, L; Fosså, SD; Glashan, RW; Jones, WG | 1 |
| Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K | 1 |
| Aamdal, S; Andersson, R; Bjelkengren, G; Ingvar, C; Jungnelius, U; Karlsson, M; Malmström, P; Mattsson, J; Ringborg, U; Stierner, U; Westberg, R; Willman, K; Wist, E | 1 |
| Akira, M; Atagi, S; Hosoe, S; Kawaguchi, T; Kawahara, M; Mitsuoka, S; Naka, N; Ogawara, M; Okishio, K; Sunami, T | 1 |
| Abe, K; Adachi, I; Suzuki, M; Tsuchihashi, T; Watanabe, T; Yamaguchi, K; Yin, DF | 1 |
| Eguchi, K; Fujita, J; Futami, H; Saijo, N; Sasaki, Y; Shimizu, E; Shinkai, T; Tominaga, K | 1 |
| Birch, R; Hake, J; Logan, T; Luedke, DW; Luedke, SL; Martelo, O; Quesenberry, P; Schlueter, J | 1 |
| Jurd, J; Vincent, PC; Young, GA | 1 |
6 trial(s) available for vindesine and Hematologic Diseases
| Article | Year |
|---|---|
Inefficacy of vindesine monotherapy in advanced stage IV malignant melanoma patients previously treated with other chemotherapeutic agents.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Salvage Therapy; Skin Neoplasms; Treatment Outcome; Vindesine | 2003 |
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine | 1996 |
Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Nausea; Prospective Studies; Regression Analysis; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vindesine; Vomiting | 1998 |
A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Feasibility Studies; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiation Dosage; Survival Rate; Treatment Failure; Vindesine | 2002 |
Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Nausea; Time Factors; Vinblastine; Vindesine | 1985 |
Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: a Southeastern Cancer Study Group Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Mitomycins; Peripheral Nervous System Diseases; Vindesine | 1986 |
5 other study(ies) available for vindesine and Hematologic Diseases
| Article | Year |
|---|---|
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Paris; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Vindesine | 2002 |
Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cisplatin; Dogs; Drug Administration Schedule; Drug Evaluation; Etoposide; Hematologic Diseases; Humans; Lung Neoplasms; Middle Aged; Time Factors; Vinblastine; Vindesine | 1984 |
An EORTC phase II study of vindesine in advanced prostate cancer.
Topics: Aged; Antineoplastic Agents; Drug Evaluation; Hematologic Diseases; Humans; Male; Middle Aged; Nervous System Diseases; Prostatic Neoplasms; Time Factors; Vinblastine; Vindesine | 1983 |
Effects of continuous vindesine administration of advanced breast cancer resistant to chemotherapy including adriamycin.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Middle Aged; Receptors, Estrogen; Remission Induction; Survival Rate; Tamoxifen; Vindesine | 1991 |
Vindesine in the treatment of refractory haematological malignant diseases.
Topics: Adolescent; Adult; Aged; Female; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Lymphoma; Male; Middle Aged; Vinblastine; Vindesine | 1985 |